iTonic Holdings Ltd Announces 16-for-1 Share Consolidation

BEIJING, China, Oct. 02, 2026 /CourierPR/ -- iTonic Holdings Ltd, a healthcare company developing digital medical technologies, has announced a significant corporate restructuring. At an extraordinary general meeting held on September 9, 2026, shareholders approved a 16-for-1 share consolidation of the company’s Class A and Class B ordinary shares. This consolidation will combine every sixteen Class A Ordinary Shares, each with a par value of US$0.0001, into one Class A Ordinary Share, with a par value of US$0.0016. Similarly, every sixteen Class B Ordinary Shares, each with a par value of US$0.0001, will be consolidated into one Class B Ordinary Share, with a par value of US$0.0016.

The Share Consolidation is scheduled to take effect at 12:01 a.m. Eastern Time on October 6, 2026. Upon the opening of the market on that date, the company’s Class A Ordinary Shares are expected to begin trading on The Nasdaq Capital Market under the current symbol “ITOC.” The new CUSIP number for the Class A Ordinary Shares following the Share Consolidation will be G71399110, replacing the current CUSIP number G71399102.

The Share Consolidation will reduce the issued and outstanding Class A Ordinary Shares from 109,382,000 to approximately 6,836,375 and the issued and outstanding Class B Ordinary Shares from 7,668,000 to approximately 479,250. The company’s authorized share capital will remain US$50,000, divided into 25,000,000 Class A Ordinary Shares and 6,250,000 Class B Ordinary Shares, each with a par value of US$0.0016. However, the Share Capital Increase approved at the EGM will increase the authorized share capital to US$800,000, divided into 400,000,000 Class A Ordinary Shares and 100,000,000 Class B Ordinary Shares, each with a par value of US$0.0016. This increase creates additional authorized but unissued shares and does not increase the number of shares outstanding.

Proportionate adjustments will be made to the number of shares issuable and the exercise or conversion prices under any outstanding options, warrants, and convertible or exchangeable securities, and to share reserves under the company’s equity incentive plans, in accordance with their respective terms.

The Share Consolidation is intended to increase the trading price per Class A Ordinary Share to support the company’s efforts to regain compliance with the US$1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). As previously disclosed, Nasdaq granted the company until October 19, 2026, to regain compliance. There can be no assurance that the Share Consolidation will enable the company to regain or maintain compliance with Nasdaq’s listing requirements.

iTonic Holdings Ltd is a technology-driven healthcare company focused on developing innovative digital medical solutions. Through strategic investments and technology partnerships, the company seeks to advance healthcare transformation through artificial intelligence, automation, and intelligent data platforms.